메뉴 건너뛰기




Volumn 33, Issue 9, 2002, Pages 2279-2284

Microplasmin: A novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits

Author keywords

Ischemia; Neuroprotection; Rabbits; Reperfusion; Thrombolytic therapy; Tissue plasminogen activator

Indexed keywords

FIBRINOLYTIC AGENT; MICROPLASMIN; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

EID: 0036712353     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000028267.09604.7B     Document Type: Article
Times cited : (98)

References (26)
  • 3
    • 0033551483 scopus 로고    scopus 로고
    • Thrombolytic stroke therapy: Past, present, and future
    • (1999) Neurology , vol.53 , pp. 14-19
    • Zivin, J.A.1
  • 5
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • (1995) N Engl J Med , vol.333 , pp. 1581-1587
  • 6
    • 0035148402 scopus 로고    scopus 로고
    • Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: Combination studies with the thrombolytic tissue plasminogen activator
    • (2001) Stroke , vol.32 , pp. 147-153
    • Lapchak, P.A.1    Chapman, D.F.2    Zivin, J.A.3
  • 8
    • 0035215147 scopus 로고    scopus 로고
    • Reducing bleeding complications after thrombolytic therapy for stroke: Clinical potential of metalloproteinase inhibitors and spin trap agents
    • (2001) CNS Drugs , vol.15 , pp. 819-829
    • Lapchak, P.A.1    Araujo, D.M.2
  • 10
    • 0036370325 scopus 로고    scopus 로고
    • Hemorrhagic transformation following ischemic stroke: Significance, causes, and relationship to therapy and treatment
    • (2002) Curr Neurol Neurosci Rep , vol.2 , pp. 1-6
    • Lapchak, P.A.1
  • 17
    • 0036098259 scopus 로고    scopus 로고
    • Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: Combination studies with the thrombolytic tissue plasminogen activator
    • (2002) Stroke , vol.33 , pp. 1411-1415
    • Lapchak, P.A.1    Araujo, D.M.2    Song, D.3    Wei, J.4    Zivin, J.A.5
  • 18
    • 0036142821 scopus 로고    scopus 로고
    • The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced cerebral hemorrhage after thromboembolic stroke
    • (2002) Stroke , vol.33 , pp. 147-152
    • Lapchak, P.A.1    Araujo, D.M.2    Song, D.3    Zivin, J.A.4
  • 19
    • 0036281174 scopus 로고    scopus 로고
    • Effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model: Combination studies with tissue plasminogen activator
    • (2002) Stroke , vol.33 , pp. 1665-1670
    • Lapchak, P.A.1    Araujo, D.M.2    Song, D.3    Wei, J.4    Purdy, R.5    Zivin, J.A.6
  • 20
  • 23
    • 0029070798 scopus 로고
    • Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin: A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen
    • (1995) J Clin Invest , vol.95 , pp. 2483-2490
    • Wu, J.H.1    Diamond, S.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.